Invitation to presentation of Bactiguard’s year end report for 2016 on February 9, 2017
Bactiguard Holding AB (publ) publishes the year end report for 2016 on Thursday, February 9, 2017 at 8:00 CET.
In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on February 9. CEO Christian Kinch and CFO Fredrik Järrsten will present the report and answer questions.
The year end report and a presentation for the conference call will be available at Bactiguard’s website www.bactiguard.com from 8:00 CET the same day.
To participate in the conference call, please dial +46 8 566 426 99
For further information, please contact:
Fredrik Järrsten, CFO, mobile: +46 725 500 089
Bactiguard is a Swedish medtech company with a global presence, offering a solution that prevents healthcare associated infections caused by medical devices. By preventing infections, we contribute to a reduced use of antibiotics and the spread of multi-resistant bacteria, which is a growing problem worldwide. We save lives, increase patient safety and significantly reduce the cost for the healthcare and society. Our technology is well-proven, safe and tissue friendly and consist of a thin layer of noble metals that prevents bacterial growth. The coating can be applied on almost all medical devices. Bactiguard-coated urinary catheters are market leading in the US and Japan and the company has also its own product portfolio consisting of Foley catheters, central venous catheters and endotracheal tubes. Bactiguard is a growth company, focused on markets in Europe, Middle East, Asia and Latin America. The company has about 60 employees worldwide, mainly at the headquarters in Stockholm and the production facility in Malaysia and is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com